GLP-1 receptor agonist analog for metabolic research.
Tirzepatide
Dual GIP/GLP-1 receptor agonist for metabolic pathway research.
$119.00 / 10mg
For laboratory research use only. Not for human or veterinary use, consumption, or therapeutic application.
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist analog used in advanced metabolic research. Supplied for laboratory investigation only.
A Certificate of Analysis (COA) is available for this batch upon request or with eligible orders.
- Dual incretin pathway research compound
- Studied in body composition models
- Batch-tested for identity and purity
- Clear labeling and documentation
| Form | Lyophilized powder |
|---|---|
| Purity | ≥99% |
| Appearance | White lyophilized cake |
| Storage | 2–8°C; avoid repeated freeze-thaw |
| Solubility | Reconstitute with sterile research solvent |
Research use only. Experimental concentrations should follow published protocols. Not intended for diagnostic or therapeutic applications.
Dosage information is provided for research reference only and does not constitute medical advice or usage instructions for humans or animals.